You can select text on your screen to have it read aloud

New series leaflets/booklets

In collaboration with various organizations and doctors, we have developed a number of series with new folders/booklets in at least 5 languages. Think of new brochures about AVM, CMTC, DCMO, Klippel-Trenaunay. We would like to thank the European Commission for sponsoring the development of the Parent Support Guide. More information

Annual report 2021 published

Euro

We have, once again, published our annual report and our annual accounts. We would like to summarise a few points. We are totally transparent. We display our financial figures, annual reports, Articles of Association, etc on our website. Not only is this required by law, but we want to do this as an organisation, too. […]

Our Eden has won another prize!

Eden Quine-Taylor

Congratulations to Eden Quine-Taylor, aged 18, from Crickhowell in Wales, who has won our Ones to Watch award (sponsored by EON Productions) at the 2022 Into Film Awards. Eden has CMTC and is also one of our ambassadors. More information about the prize More information about Eden

Information & registration worldwide Members’ Conference 2022

After our last ‘real’ global Members Conference in 2019, it has not been possible for a number of years due to COVID-19 to organize a conference where you can see each other in person. In 2022 this will be possible again and that is also our 25th anniversary year!

Family Day 2 July 2022: de Efteling

Finally we can organize our International Family Day again! On Saturday 2 July we are going to the Efteling! There is something for all ages to experience from Fairytale Forest to all kinds of roller coasters. More information and registration

Launch Global Dermatology Coalition

On May 25th 2022 a patient-led multi-stakeholder group of like-minded organizations – including dermatology patient organizations, health care professionals (dermatologists and dermatology nurses), researchers, and industry – announced the formation of the Global Dermatology Coalition. This announcement comes during the 75th World Health Assembly in Geneva, as a first step in changing perceptions about the […]

Approval alpelisib by FDA

Novartis’ medicine Vijoice® (alpelisib) has recently (6 April) been approved by the US Food and Drug Administration (FDA) for the treatment of patients aged two years and older with severe manifestations of PIK3CA-related overgrowth syndrome (PROS). Until today, the only treatment options for these patients are surgical or interventional radiology procedures. More information

Translation team Zuyd University of Applied Sciences 2022

Our organization operates worldwide, which means that we offer our information in multiple languages. For example, our website is available in English and Dutch and our information leaflets in at least German, English, French, Dutch and Spanish. The translation work takes quite some time and we are always looking for volunteers to help. Zuyd Vertalingen […]

CMTC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.